Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Low-risk Myelodysplastic Syndrome”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06614595
What this trial is testing

Transfusion in Lower Risk MDS Patients: Predictors of Adequacy of Transfusion and Quality of Life in Lower Risk MDS

Who this might be right for
Low Risk Myelodysplastic Syndromes
Fundación para la Investigación Biosanitaria del Principado de Asturias 30
Not applicableStudy completedNCT00005799
What this trial is testing

Fludarabine Phosphate, Low-Dose Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+42 more
Fred Hutchinson Cancer Center 55
Early research (Phase 1)Study completedNCT00008177
What this trial is testing

Radiolabeled Monoclonal Antibody Therapy, Fludarabine Phosphate, and Low-Dose Total-Body Irradiation Followed by Donor Stem Cell Transplant and Immunosuppression Therapy in Treating Older Patients With Advanced Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes

Who this might be right for
Adult Acute Myeloid Leukemia in RemissionAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)+14 more
Fred Hutchinson Cancer Center
Post-approval studies (Phase 4)Ended earlyNCT01326845
What this trial is testing

Myelodysplastic Syndrome (MDS) Gastrointestinal (GI) Tolerability Study

Who this might be right for
Myelodysplastic SyndromeTransfusional Iron Overload
Novartis Pharmaceuticals 12
Large-scale testing (Phase 3)Study completedNCT00322101
What this trial is testing

Low-Dose or High-Dose Conditioning Followed by Peripheral Blood Stem Cell Transplant in Treating Patients With Myelodysplastic Syndrome or Acute Myelogenous Leukemia

Who this might be right for
Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAcute Myeloid Leukemia/Transient Myeloproliferative DisorderAdult Acute Myeloid Leukemia in Remission+16 more
Fred Hutchinson Cancer Center 25
Large-scale testing (Phase 3)Active Not RecruitingNCT06045689
What this trial is testing

Assess Luspatercept in Lower-risk Myelodysplastic Syndrome Participants

Who this might be right for
Myelodysplastic Syndromes
Bristol-Myers Squibb 106
Testing effectiveness (Phase 2)Study completedNCT00516828
What this trial is testing

Sorafenib and Low Dose Cytarabine in Older Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

Who this might be right for
LeukemiaMyelodysplastic Syndromes
NCIC Clinical Trials Group 21
Testing effectiveness (Phase 2)Ended earlyNCT00740181
What this trial is testing

Decitabine, Cytarabine, GCSF for Refractory AML/MDS

Who this might be right for
MyelodysplasiaLeukemia
Brown University 9
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07463820
What this trial is testing

A Trial Comparing Three Different Treatment Options for Adults With Low-Risk Myelodysplasia and Anemia (A MyeloMATCH Treatment Trial)

Who this might be right for
Myelodysplastic Syndrome
National Cancer Institute (NCI) 270
Testing effectiveness (Phase 2)Study completedNCT00812968
What this trial is testing

Study of CC-5013 to Evaluate Safety, Pharmacokinetics and Effectiveness for Japanese Patients With Symptomatic Anemia Associated With Myelodysplastic Syndrome With a Del(5)(q31-33) Abnormality.

Who this might be right for
Myelodysplastic Syndromes
Celgene 11
Testing effectiveness (Phase 2)Study completedNCT00551291
What this trial is testing

NeoRecormon (Epoetin Beta), CellCept (Mycophenolate Mofetil) and Prednisone in Patients With Low or Intermediate Myelodysplastic Syndromes.

Who this might be right for
Myelodysplastic Syndromes
Hoffmann-La Roche 10
Early research (Phase 1)Study completedNCT01062152
What this trial is testing

Dose-Ranging Study of Telintra® Tablets + Revlimid® in Patients With Non-Deletion (5q) Low to Intermediate-1 Risk Myelodysplastic Syndrome (MDS)

Who this might be right for
Myelodysplastic Syndrome
Telik 19
Testing effectiveness (Phase 2)WithdrawnNCT06020833
What this trial is testing

A Single-arm Trial of Roxadustat Combined With Retinoic Acid in the Treatment of Refractory Low-risk MDS

Who this might be right for
Myelodysplastic Syndromes
Peking Union Medical College Hospital
Early research (Phase 1)Ended earlyNCT00458159
What this trial is testing

A Phase I, Open-Label, Dose-Escalation Study of CC-11006 In Subjects With Low- or Intermediate-1 Risk Myelodysplastic Syndromes

Who this might be right for
Myelodysplastic Syndrome
Celgene 34
Testing effectiveness (Phase 2)Ended earlyNCT01459159
What this trial is testing

Study of (Telintra®) in Non-Del(5q) Myelodysplastic Syndrome

Who this might be right for
Myelodysplastic Syndrome (MDS)
Telik 162
Early research (Phase 1)Looking for participantsNCT07283094
What this trial is testing

FHD-286 With Low-Dose Weekly Decitabine/Venetoclax in Patients With Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndrome
Montefiore Medical Center 33
Testing effectiveness (Phase 2)Study completedNCT00700206
What this trial is testing

Phase 2 Study Comparing Two Dose Schedules of Telintra™ in Myelodysplastic Syndrome (MDS)

Who this might be right for
Myelodysplastic Syndrome (MDS)
Telik 86
Not applicableStudy completedNCT01739452
What this trial is testing

Spanish Registry of Erythropoietic Stimulating Agents Study

Who this might be right for
Myelodysplastic Syndrome
Grupo Español de Síndromes Mielodisplásicos 722
Testing effectiveness (Phase 2)Study completedNCT00067808
What this trial is testing

Study of Three Different Schedules of Low-Dose Decitabine in Myelodysplastic Syndrome (MDS)

Who this might be right for
Myelodysplastic SyndromeChronic Myelomonocytic Leukemia
M.D. Anderson Cancer Center 128
Testing effectiveness (Phase 2)UnknownNCT00513578
What this trial is testing

Vaccine Therapy and GM-CSF in Treating Patients With Low-Risk or Intermediate-Risk Myelodysplastic Syndrome

Who this might be right for
Myelodysplastic Syndromes
The Vaccine Company 30
Next Page
79